Panel Critiques TAG Graft Study Size, But Deems Approval “Common Sense”
This article was originally published in The Gray Sheet
Executive Summary
The appeal of WL Gore's TAG thoractic endograft as a less-invasive alternative to open-heart surgery swayed FDA panelists to recommend device approval Jan. 13